Business Description
BL Pharmtech Corp
ISIN : KR7065170003
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.1 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -1.35 | |||||
Beneish M-Score | -3.59 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -32.2 | |||||
3-Year EBITDA Growth Rate | 0.5 | |||||
3-Year EPS without NRI Growth Rate | 6.6 | |||||
3-Year Book Growth Rate | -22.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.51 | |||||
9-Day RSI | 65.16 | |||||
14-Day RSI | 61.48 | |||||
6-1 Month Momentum % | -3.84 | |||||
12-1 Month Momentum % | -35.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 1.89 | |||||
Cash Ratio | 1.66 | |||||
Days Inventory | 335.87 | |||||
Days Sales Outstanding | 128.99 | |||||
Days Payable | 163.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 29.48 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.3 | |||||
Operating Margin % | -27.7 | |||||
Net Margin % | -0.61 | |||||
FCF Margin % | 31.31 | |||||
ROE % | -0.49 | |||||
ROA % | -0.17 | |||||
ROIC % | -7.68 | |||||
ROC (Joel Greenblatt) % | -32.27 | |||||
ROCE % | -24.54 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 6.97 | |||||
Price-to-Owner-Earnings | 1333.33 | |||||
PS Ratio | 1.79 | |||||
PB Ratio | 1.4 | |||||
Price-to-Tangible-Book | 1.42 | |||||
Price-to-Free-Cash-Flow | 5.71 | |||||
Price-to-Operating-Cash-Flow | 5.49 | |||||
EV-to-EBIT | -2.85 | |||||
EV-to-EBITDA | -3.74 | |||||
EV-to-Revenue | 1.42 | |||||
EV-to-FCF | 4.44 | |||||
Price-to-Median-PS-Value | 1.42 | |||||
Price-to-Graham-Number | 0.66 | |||||
Price-to-Net-Current-Asset-Value | 12.42 | |||||
Earnings Yield (Greenblatt) % | -35.15 | |||||
FCF Yield % | 17.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BL Pharmtech Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 24,525.173 | ||
EPS (TTM) (â‚©) | -2.102 | ||
Beta | 1.13 | ||
Volatility % | 53.66 | ||
14-Day RSI | 61.48 | ||
14-Day ATR (â‚©) | 25.193878 | ||
20-Day SMA (â‚©) | 467.3 | ||
12-1 Month Momentum % | -35.75 | ||
52-Week Range (â‚©) | 322 - 930 | ||
Shares Outstanding (Mil) | 88.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BL Pharmtech Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BL Pharmtech Corp Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
BL Pharmtech Corp Frequently Asked Questions
What is BL Pharmtech Corp(XKRX:065170)'s stock price today?
When is next earnings date of BL Pharmtech Corp(XKRX:065170)?
Does BL Pharmtech Corp(XKRX:065170) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |